TWO SIGMA INVESTMENTS, LP - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,460
-81.6%
17,900
-57.6%
0.00%
Q2 2023$29,709
-49.8%
42,200
-36.1%
0.00%
Q1 2023$59,195
-82.6%
66,000
-77.1%
0.00%
-100.0%
Q4 2022$340,241
-10.7%
288,340
+469.6%
0.00%0.0%
Q3 2022$381,000
-2.3%
50,619
-18.3%
0.00%0.0%
Q2 2022$390,000
+73.3%
61,964
+128.7%
0.00%0.0%
Q1 2022$225,000
+24.3%
27,092
+0.2%
0.00%
Q3 2021$181,000
-37.6%
27,027
-20.6%
0.00%
-100.0%
Q2 2021$290,000
-81.6%
34,032
-80.9%
0.00%
-75.0%
Q1 2021$1,577,000
-47.2%
178,167
-26.7%
0.00%
-55.6%
Q4 2020$2,987,000
+31.3%
243,029
-13.0%
0.01%
+12.5%
Q3 2020$2,275,000
+6.5%
279,486
+25.6%
0.01%
-27.3%
Q2 2020$2,136,000
+48.5%
222,504
+5.2%
0.01%
-8.3%
Q1 2020$1,438,000
-3.0%
211,497
+112.6%
0.01%
+200.0%
Q4 2019$1,482,000
+476.7%
99,464
+296.1%
0.00%
+300.0%
Q3 2019$257,000
-68.7%
25,113
-67.6%
0.00%
-66.7%
Q2 2019$821,000
-26.9%
77,439
-3.6%
0.00%
-25.0%
Q1 2019$1,123,000
+171.9%
80,315
+97.6%
0.00%
+100.0%
Q4 2018$413,000
+38.1%
40,644
+63.1%
0.00%
+100.0%
Q3 2018$299,000
+3.8%
24,924
+5.6%
0.00%0.0%
Q2 2018$288,00023,6070.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 217,029$2,225,0006.42%
Knoll Capital Management, LLC 350,238$3,590,0003.29%
INTERWEST VENTURE MANAGEMENT CO 764,918$7,840,0003.01%
Broadfin Capital, LLC 1,367,377$14,016,0002.59%
P.A.W. CAPITAL CORP 200,000$2,050,0002.56%
683 Capital Management, LLC 1,860,529$19,071,0002.12%
EcoR1 Capital, LLC 1,060,043$10,865,0001.37%
MANGROVE PARTNERS IM, LLC 847,284$8,685,0001.05%
KNOTT DAVID M 234,448$2,403,0001.01%
Trellus Management Company, LLC 85,000$871,0000.87%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders